129 related articles for article (PubMed ID: 8402921)
21. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
Lauwerys BR; Renauld JC; Houssiau FA
Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-1 augments the interleukin-2-dependent generation of natural killer cells from bone marrow precursors.
Migliorati G; Cannarile L; D'Adamio L; Herberman RB; Riccardi C
Nat Immun Cell Growth Regul; 1987; 6(6):306-15. PubMed ID: 3502358
[TBL] [Abstract][Full Text] [Related]
23. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells.
Yamauchi A; Bloom ET
J Immunol; 1993 Nov; 151(10):5535-44. PubMed ID: 8228244
[TBL] [Abstract][Full Text] [Related]
24. OK-432 stimulates primary production and activity of murine natural killer cells.
Pollack SB
Nat Immun Cell Growth Regul; 1987; 6(5):224-36. PubMed ID: 3444437
[TBL] [Abstract][Full Text] [Related]
25. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
[TBL] [Abstract][Full Text] [Related]
26. Population dynamics of natural killer cells in the spleen and bone marrow of normal and leukemic mice during in vivo exposure to interleukin-2.
Christopher FL; Dussault I; Miller SC
Immunobiology; 1991 Dec; 184(1):37-52. PubMed ID: 1800310
[TBL] [Abstract][Full Text] [Related]
27. Development of natural killer cells from lymphohematopoietic progenitors of murine fetal liver.
Aiba Y; Ogawa M
Stem Cells; 1998; 16 Suppl 1():193-8. PubMed ID: 11012162
[TBL] [Abstract][Full Text] [Related]
28. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
29. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
[TBL] [Abstract][Full Text] [Related]
30. Continuous administration of Il-13 to mice induces extramedullary hemopoiesis and monocytosis.
Lai YH; Heslan JM; Poppema S; Elliott JF; Mosmann TR
J Immunol; 1996 May; 156(9):3166-73. PubMed ID: 8617937
[TBL] [Abstract][Full Text] [Related]
31. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
Gaddy J; Broxmeyer HE
Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
[TBL] [Abstract][Full Text] [Related]
32. Development of B cells in aged mice: decline in the ability of pro-B cells to respond to IL-7 but not to other growth factors.
Stephan RP; Lill-Elghanian DA; Witte PL
J Immunol; 1997 Feb; 158(4):1598-609. PubMed ID: 9029095
[TBL] [Abstract][Full Text] [Related]
33. In vitro generation of natural killer cells from SJL/J bone marrow precursors.
D'Adamio L; Cannarile L; Migliorati G; Riccardi C
J Biol Regul Homeost Agents; 1988; 2(2):71-6. PubMed ID: 3263749
[TBL] [Abstract][Full Text] [Related]
34. Activity of stem cell factor and IL-7 in combination on normal bone marrow B lineage cells.
Funk PE; Varas A; Witte PL
J Immunol; 1993 Feb; 150(3):748-52. PubMed ID: 7678620
[TBL] [Abstract][Full Text] [Related]
35. The influence of S17 stromal cells and interleukin 7 on B cell development.
Cumano A; Dorshkind K; Gillis S; Paige CJ
Eur J Immunol; 1990 Oct; 20(10):2183-9. PubMed ID: 2242755
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 2. The role of non-activated and rIL-2-activated CD4+ and CD8+ T cells in immunotherapy for leukemia.
Weiss L; Reich S; Slavin S
Cytokines Cell Mol Ther; 1999 Sep; 5(3):153-8. PubMed ID: 10641573
[TBL] [Abstract][Full Text] [Related]
37. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J
Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270
[TBL] [Abstract][Full Text] [Related]
38. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
[TBL] [Abstract][Full Text] [Related]
39. Murine hepatocyte cell lines promote expansion and differentiation of NK cells from stem cell precursors.
Bordoni V; Alonzi T; Agrati C; Poccia F; Borsellino G; Mancino G; Fimia GM; Piacentini M; Fantoni A; Tripodi M
Hepatology; 2004 Jun; 39(6):1508-16. PubMed ID: 15185291
[TBL] [Abstract][Full Text] [Related]
40. The primary role of murine bone marrow in the production of natural killer cells. A cytokinetic study.
Pollack SB; Rosse C
J Immunol; 1987 Oct; 139(7):2149-56. PubMed ID: 3655362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]